Funded Tech Companies
Avrobio
Avrobio, based in Cambridge, received equity investments from Brace Pharma, Morningside Group and Aisling Capital.
Company Overview
Company Name
Avrobio
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1 Kendall Sq. Building 300 201
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Company Background Information
Overview
AVROBIO is a clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease. The catalyst for creating AVROBIO is to accelerate scientific breakthroughs related to the convergence of cell and gene therapies.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/2/2018
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Geoff MacKay
Chief Scientific Officer
Chris Mason
Vice President
Kathryn McNaughton
VP - Bus. Development
Deanna Petersen
VP - Operations
Kim Warren
Company Investors
- Brace Pharma
- Morningside Group
- Aisling Capital
- Clarus (Scott Requadt)
- Atlas Venture (Bruce Booth)
- SV Health Investors (Joshua Resnick)
- Cormorant Asset Management
- Eventide Asset Management
- Surveyor Capital
- Atlas Accelerator (Bruce Booth)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs